| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.40B | +1.6% |
| Cost of Revenue | $936.9M | -0.1% |
| Gross Profit | $464.3M | +5.3% |
| R&D Expense | $129.3M | +9.6% |
| SG&A Expense | $101.8M | -21.9% |
| Operating Income | -$13.7M | -3.0% |
| Pre-tax Income | -$4.5M | -125.8% |
| Income Tax | $7.5M | -67.3% |
| Net Income | -$12.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $165.9M | -48.0% |
| Short-term Investments | $96.9M | — |
| Accounts Receivable | $256.7M | +4.7% |
| Current Assets | $593.9M | -5.6% |
| Total Assets | $1.53B | -4.2% |
| Current Liabilities | $368.2M | -8.1% |
| Stockholders' Equity | $834.5M | +8.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $53.5M | -15.8% |
| Capital Expenditures | $34.9M | -10.6% |
| Investing Cash Flow | -$139.6M | +77.5% |
| Financing Cash Flow | -$62.9M | -110.0% |
| Free Cash Flow | $18.6M | -24.1% |
| +52.0% |
| EPS (Basic) | -$0.05 | +80.8% |
| EPS (Diluted) | -$0.05 | +80.8% |